Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzymatic Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117106845A reveals enzymatic resolution for chiral pyridine diols. This method offers mild conditions and high atom economy for pharmaceutical intermediate manufacturing supply chains.
Patent CN101130503B details a robust synthesis route for L-Serine-15N. Achieves high 15N abundance and purity for reliable supply chain integration.
Advanced synthesis of HIV integrase inhibitor intermediates via patent CN114394983A. Offers scalable routes and high-purity enzymatic resolution for global pharmaceutical supply chains.
Patent CN114214375A details a novel enzymatic route for high-purity Ruxolitinib intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN110358752A reveals enzymatic route for high-purity Brivaracetam intermediate. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN102660625A details enzymatic synthesis for high purity. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN105200076A reveals high-purity gamma-lactam production. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN111194304B details an enzymatic method for chiral bridged rings. Offers high ee values and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN103228640B details enzymatic resolution for nebivolol. This reduces waste and avoids HPLC, offering cost reduction in pharmaceutical intermediates manufacturing.
Patent CN109053526A details efficient synthesis. Enhances supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing for global buyers.
Patent CN110643670A details a high-yield chemoenzymatic route for D-glutamine production, offering significant cost reduction in pharmaceutical manufacturing and scalable supply solutions.
Novel enzymatic resolution method for chiral spiro compounds. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Patent CN109762768B details a novel Bacillus B8W22 strain for producing high-purity pharmaceutical intermediates with superior stereoselectivity and reduced environmental impact.
Patent CN102533888B enables continuous enzymatic production of high-purity L-tert-leucine. Reduces costs and ensures supply chain reliability for API manufacturing.
Patent CN104178548A details high-purity S-2-naphthylethylamine synthesis via lipase. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN104178546A details high-yield enzymatic resolution for S-1-naphthylethylamine. Offers superior purity and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN104178547B analysis reveals enzymatic resolution for high purity. Supply chain advantages and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN105420338B reveals lipase fractionation for high-purity L-Valsartan. Enhances supply chain reliability and reduces environmental impact for global pharmaceutical manufacturing.
Patent CN104557911B reveals enzymatic deracemization for levo-praziquantel. Achieve high optical purity and cost reduction in pharmaceutical intermediates manufacturing with scalable green chemistry.
Novel enzymatic route for Sacubitril intermediates offers cost reduction in API manufacturing. High-purity cardiovascular drug synthesis suitable for commercial scale-up.